10:13 AM EST - Medicenna Therapeutics Corp. : Has received conditional approval from the Toronto Stock Exchange to extend the expiry date of a total of 1,549,052 outstanding common share purchase warrants of the Company originally issued on October 17, 2019 as part of a public offering of units of the Company. Each warrant is exercisable for a common share of the Company at a price of $1.75 per Common Share and set to expire on July 17. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.05 at $0.70.
